Closed transaction
Indigo
Description
Sale of Arjessa to Swedish publicly listed Humana. Arjessa is a leading Finnish high-quality provider of full responsibility psychiatric and psychosocial treatments for children, adolescents and their families. Arjessa had sales of EUR 32m and EBITDA of EUR 3.1m. The transaction was closed in June 2016.
Deal team
Members of this deal.
Deal announcement
Sell-side advisoryConfidential, subject to NDA. Sell-side pitch - Leading Nordic niche consulting firm providing innovation/EU funding consulting services
Deal announcement
Sell-side advisoryThe shareholders of TSS. Sale of TSS - a niche pharmatech player
Deal announcement
Sell-side advisory"Daytona". Potential sale of "Daytona"
Deal announcement
Buy-side advisoryConfidential. We are pitching for a Buy-side mandate: an Indian plant-extract ingredients company wants to buy profitable extract makers or distributors in the US, Europe…
Deal announcement
Sell-side advisoryVPD Bled d.o.o.. Company specialized in Wholesale Distribution & Retail of Medical Devices, offering a broad portfolio of healthcare products across respiratory care, blood pressure monitoring, rehabilitation,…
Deal announcement
Sell-side advisoryUndisclosed. We are pitching for the sale of a UK-based manufacturer and supplier of high-quality single-use surgical instruments and devices